Research use only. All compounds are for laboratory research. Not for human or veterinary use. 21+.

IGF-1 LR3, 1 mg

Lot VA-2606-6779, analysed 2026-06-12

Traceability. The analytical report behind this certificate names the manufacturing lot, and the vials sold under VA-2606-6779 were filled from it. The lot identifier itself stays internal: it is shared with every brand the manufacturer fills for, and publishing it would let anyone match this material to a certificate issued under another name.

Results

TestSpecification ResultStatus
Appearance Visual inspection White lyophilized powder Conforms PASS
Identity LC-MS IGF-1 LR3 confirmed, mass matches 9117.50 g/mol Conforms PASS
Purity HPLC-UV, area % · UV 214 nm ≥ 98.0 % 99.91 % PASS
Net content As reported by the laboratory 90-110 % of label (1 mg) 1.05 mg (105.0 % of label) PASS
Microbial sterility screen Growth accelerator No growth No growth PASS
Bacterial endotoxin LAL < 0.5 EU/mL Pass PASS
Heavy metals Pb · Cd · As · Hg Negative Negative (all four) PASS

No chromatogram is reproduced. Vantage plots a figure only from the instrument's own exported data or one reissued by the laboratory; neither is held for this lot. Results above are transcribed from the laboratory report retained unaltered on file.

Open the certificate (PDF, opens in a new tab) Go to IGF-1 LR3 All batch records

Identity and handling

Specimen readout VA-IGF1LR3-1MG
FORMULA
C400H625N111O115S9
MOL. WEIGHT
9117.6
FORM
White lyophilized powder
FILL
1 mg
CONTAINER
3 mL vial
MANUFACTURED
2026-03-21
FILLED
2026-03-27
ANALYSED
2026-06-12
RETEST BY
2028-03-21
STORAGE
Refrigerated, 2-8 °C, protected from light
DOCUMENT
COA-VA-2606-6779 rev 1.1

Method

  • Technique HPLC-UV, area % · UV 214 nm
  • MS technique LC-MS
  • Theoretical mass 9117.50 g/mol
  • Observed mass Matches

For research use only. Not for human or veterinary use. Not approved by the FDA. 21+